"We will be carefully monitoring the recruitment of patients in this trial, and report progress as we go".
And so danger I alluded to yesterday is revealed. If the first report is anywhere near what we expect, this will have a 1 in front of it before you can blink.
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-3
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
83.0¢ |
Change
-0.015(1.78%) |
Mkt cap ! $102.6M | |||
| Open | High | Low | Value | Volume |
| 84.5¢ | 84.5¢ | 80.0¢ | $64.05K | 78.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 124 | 83.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.0¢ | 6500 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AGN (ASX) Chart |